Pharmacy Tech CEU
Contact Hours: 1.0 (0.1 CEUs)

Course Summary

Tramadol is a synthetic, schedule IV opioid that is used for the treatment of acute and long-term pain, and as an analgesic agent in perioperative clinical settings. Tramadol is widely prescribed in the US and worldwide. Its historical popularity was partly due to its perceived favorable side effects profile and safety, and the perception that it was less likely to be misused than other short-acting opioids; however, tramadol may be just as misused as other opioids. Tramadol remains a popular drug to prescribe, and it does provide positive patient outcomes when it is used properly; however, it is not indicated for all patient populations, and for some patients dosing should be adjusted. Because of tramadol’s pharmacodynamics, it can cause an accidental overdose. In these cases, tramadol can cause serious morbidities and death.

Course Objectives

Describe the basic pharmacological profile, use, and clinical outcomes of tramadol treatment.

Identify the dosing for tramadol for the treatment of acute and long-term pain.

Compare the benefits and risks of tramadol compared to other drugs used to treat acute and long-term pain.

Identify the contraindications and potential side effects of tramadol.

I. Introduction

II. Natural and Synthetic Opioids

III. History of Tramadol

IV. Pharmacologic Profile

1. Mechanism of Action
2. Labeled Uses
3. Off-label Uses
4. Future Trends in Tramadol Use
5. Available Forms
6. Dosing for Tramadol
7. Dosing Adjustments for Certain Patient Groups

V. Side Effects and Warnings for Tramadol Use

1. US Boxed Warning
2. Contraindications
3. Warnings
4. Neurologic
5. Urologic
6. Use During Pregnancy and Breastfeeding

VI. Tramadol Use Disorder

VII. Tramadol Overdose

VIII. Treatment of Overdose

IX. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in the development of this activity: Susan DePasquale, MSN, PMHNP-BC, Amanda Mayer, PharmD, and Jeff Goldberg, PharmD. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.

Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of LLC. LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacy Tech
  • Contact Hours: 1.0 (0.1 CEUs)
  • Activity Release Date: 8/25/2022
  • Activity Expiration Date: 8/25/2025
  • Activity Type: Knowledge
  • UAN: 0669-0000-22-012-H01-T
  • Topic: Disease State Management/Drug Therapy
  • CeBroker Number: 20-943168


Marilyn Lajoie, MD, DC, CCSP



The logo for the Accreditation Council for Pharmacy Education (ACPE)., LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The logo for the Pharmacy Technician Certification Board (PTCB).
PTCB Course Recognition, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".

‹‹ Back to Course List